Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
about
AcromegalyClinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluationSomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalySomatostatin analogues, dopamine agonists or growth hormone antagonists for pituitary adenoma-induced acromegalyAcromegaly pathogenesis and treatmentPasireotide: a novel treatment for patients with acromegalyRare causes of osteoporosisCurrent therapies and mortality in acromegalyPlace of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysisRespiratory manifestations in endocrine diseasesThe risks of overlooking the diagnosis of secreting pituitary adenomasNeurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegalyDual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosisHand and foot abnormalities associated with genetic diseasesChallenges in the diagnosis and management of acromegaly: a focus on comorbidities.Implementing a screening program for acromegaly in Latin America: necessity versus feasibilityAcromegaly and McCune-Albright syndrome.Thyroid nodules in acromegaly: The role of elastography.Evaluating the efficiency of different recording protocols for entheseal changes in regards to expressing activity patterns using archival data and cross-sectional geometric properties.Invasive Growth Hormone Producing Pituitary Adenoma With Lymphocytic Infiltration: A Case Report and Literature Review.Malignant ventricular tachycardia in acromegaly: a case report.A 52-year-old female with a hoarse voice and tingling in the handReduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegalyTreatment of acromegaly patients at the Federal University of Triângulo Mineiro (UFTM): Experience ReportThe GH/IGF-1 Axis and Heart Failure.GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment.Pegvisomant in acromegaly: an update.Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data.AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesityAdverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care populationBenign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?Perioperative management and complications in patients with obstructive sleep apnea undergoing transsphenoidal surgery: Our institutional experienceCase Report: A case report of acromegaly associated with primary aldosteronismGallbladder villous adenoma in a patient with acromegaly: a case report.Thyroid diseases in patients with acromegaly.Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineInsulin-like growth factors and neoplasia.Growth hormone treatment: cancer risk.Cushing, acromegaly, GH deficiency and tendons.
P2860
Q21202912-BA545D53-E1F2-4156-82C8-1D45211C8620Q21254711-566D967A-25C4-4C7F-8D2F-15484B4FC7A9Q24188346-86303A97-B9CB-4059-AF24-364C816D798CQ24239834-B3A39CF4-944D-497B-8518-9246083600EAQ24647360-188A89D6-EC00-4A37-B02D-926C280E7D83Q26774437-DC3868CA-5907-4408-B063-BADA7937AA02Q26775750-F281404F-3FE0-416F-8E2C-10E97C7D7584Q26776238-06A1A847-01F8-43E5-B52A-F255C4C37ECAQ27693237-6D73ABF6-5538-4A01-A2A4-73791CE78205Q28074486-5A300D6F-66DC-4114-9503-7ABF92081209Q28076665-B8BE382A-D8E9-4649-8042-337997B086BFQ28486006-47F18459-502B-44C5-BAA3-17BB8D9C766AQ28580617-4A3A633B-FF93-4C7E-8164-B4E550415090Q28972490-F2639105-E2A0-4086-AD85-79514338C53FQ30249746-731994F1-1E10-42A6-985B-BFC6AE6A8845Q30251471-1CFA228F-7EF1-4437-A17B-20D7CFA2807AQ30393779-2FA1E2EA-9A62-496B-8E29-16167B349652Q30458356-F919F7E6-9B72-4371-BCD6-EC625A28E475Q30984853-C66DFF2F-6F06-4177-947A-2E5BF4061A90Q31043574-EC943889-B947-4161-AE5D-911320DA18D1Q33164761-1428D4DD-F7ED-49C7-9D23-EBCDB1DF04B9Q33277098-52FA6F5F-A69A-4C00-A69C-7422D03C6643Q33394238-384306F1-2A89-45DA-A99C-61E99A8EFB76Q33592680-E49CB810-BD39-44B3-9B0E-923B33AD3B53Q33654009-F4119118-651F-4896-8A41-957B0BE96B5DQ33654893-9C0E03C3-6F4C-47BD-A427-A55A609DB6FFQ33725999-D704BFE5-650A-4DCB-A061-917BDEDBA3D8Q33876612-040922CD-236B-4E37-99A2-CED2AB2E14DDQ33895577-7499F2F3-6A06-47A4-A782-5C15FB4B9E30Q33903274-988162C0-44C1-4D85-836D-EBB479465B65Q34031924-D4EF4A5E-AB88-40BB-8C01-D2B8F666670BQ34050636-70862237-5106-4326-9463-3444AD412655Q34124113-2FD25355-86D1-4F2F-A043-2929632F659CQ34140846-A186C7E3-4BB7-404C-9FFB-4454E690B6FDQ34232636-37B5920A-AF13-4D94-A348-014A978C0BABQ34247186-35907DE1-F8AC-454D-881D-0C60D5D8D324Q34277844-EB2A3825-D8CB-4D35-978E-2ECA734A6905Q34330521-79007999-ACE8-4776-A9D6-10BF2E1A2EA2Q34367110-F8D267D4-930D-4A12-9769-CD27B9053465Q34561224-A44B6292-8335-43FC-8401-3CC64269FDED
P2860
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@ast
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@en
type
label
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@ast
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@en
prefLabel
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@ast
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@en
P356
P1433
P1476
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
@en
P2093
Diego Ferone
Paolo Marzullo
P304
P356
10.1210/ER.2002-0022
P577
2004-02-01T00:00:00Z